Search

everythinglearnresearchcommunity

for

Search:↓

Doctors should know how to diagnose and treat PCOS, which often involves checking for high male hormone levels and using medications to manage symptoms.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Severe insulin resistance can be managed with medication, lifestyle changes, and treatment for related conditions.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.

Cyproterone acetate effectively treats sexual disorders by reducing sexual functions and is generally well-tolerated.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

Some medications can reduce excessive hair growth in women, but more research is needed to find the best treatment combinations.

Women with excessive male-pattern hair growth should get a full hormone check-up to find and treat any underlying issues, considering both medical and emotional aspects.

Finasteride reduces hirsutism effectively with fewer side effects but is a second-choice treatment due to safety concerns.

Many acne patients have high androgen levels, which may lead to PCOD, but treatments like oral contraceptives and antiandrogens can help.

Girls with PCOS during adolescence have a higher risk of developing type 2 diabetes, and early treatment can help manage this risk.

Human skin cells contain Protease Nexin-1, and male hormones can decrease its levels, potentially affecting hair growth.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

RUM-loaded SLN shows promise for treating acne and hair loss topically.

Spironolactone may effectively treat female hair loss, especially with hyperandrogenism signs.

Male hormones worsen kidney transplant damage, but blocking them helps.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

Treatment balancing hormones stopped hair loss in most women with androgenetic alopecia.

Transgender women can develop feminine traits and improve their quality of life through hormone therapy and surgery, but results vary and access to surgery can be limited.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Hair loss in men and women is linked to high stress hormone levels and other hormonal imbalances, suggesting treatments should be customized to each person's hormones.

New pregnane derivatives are effective at inhibiting an enzyme linked to hair loss and reducing oil gland activity.

All treatments reduce hair growth; low dose flutamide most effective with fewer side effects.

Spironolactone reduces the number of androgen receptor sites in rat skin by blocking them with its metabolite.

Birth control pills help treat skin and hair growth problems linked to high male hormone levels.

Anabolic steroid users may face higher risk of severe COVID-19.